List of Excipients in API olmesartan medoxomil and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing olmesartan medoxomil and hydrochlorothiazide
Excipients in ANDA-approved (generic) drugs containing olmesartan medoxomil and hydrochlorothiazide
Detailed excipient profiles for olmesartan medoxomil and hydrochlorothiazide
Excipient focus: CELLULOSE, MICROCRYSTALLINE
olmesartan medoxomil and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
olmesartan medoxomil and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: FERRIC OXIDE RED
olmesartan medoxomil and hydrochlorothiazide drug variants containing FERRIC OXIDE RED
olmesartan medoxomil and hydrochlorothiazide drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
olmesartan medoxomil and hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
olmesartan medoxomil and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | olmesartan medoxomil and hydrochlorothiazide | 50090-7045 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
olmesartan medoxomil and hydrochlorothiazide drug variants containing FERROSOFERRIC OXIDE
olmesartan medoxomil and hydrochlorothiazide drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYPROPYL CELLULOSE
olmesartan medoxomil and hydrochlorothiazide drug variants containing HYDROXYPROPYL CELLULOSE
olmesartan medoxomil and hydrochlorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
olmesartan medoxomil and hydrochlorothiazide drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
olmesartan medoxomil and hydrochlorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
olmesartan medoxomil and hydrochlorothiazide drug variants containing HYPROMELLOSE
olmesartan medoxomil and hydrochlorothiazide drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
olmesartan medoxomil and hydrochlorothiazide drug variants containing HYPROMELLOSE 2910
olmesartan medoxomil and hydrochlorothiazide drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
olmesartan medoxomil and hydrochlorothiazide drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | olmesartan medoxomil and hydrochlorothiazide | 33342-173 |
| Physicians Total Care Inc | olmesartan medoxomil and hydrochlorothiazide | 54868-5170 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil and hydrochlorothiazide drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
olmesartan medoxomil and hydrochlorothiazide drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | olmesartan medoxomil and hydrochlorothiazide | 54868-5170 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil and hydrochlorothiazide drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
olmesartan medoxomil and hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
olmesartan medoxomil and hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | olmesartan medoxomil and hydrochlorothiazide | 54868-5170 |
| >Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
olmesartan medoxomil and hydrochlorothiazide drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
olmesartan medoxomil and hydrochlorothiazide drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
olmesartan medoxomil and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
olmesartan medoxomil and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
olmesartan medoxomil and hydrochlorothiazide drug variants containing MICROCRYSTALLINE CELLULOSE 101
olmesartan medoxomil and hydrochlorothiazide drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
olmesartan medoxomil and hydrochlorothiazide drug variants containing MICROCRYSTALLINE CELLULOSE 102
olmesartan medoxomil and hydrochlorothiazide drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POLYETHYLENE GLYCOL 3350
olmesartan medoxomil and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | olmesartan medoxomil and hydrochlorothiazide | 63629-7278 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 4000
olmesartan medoxomil and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 4000
olmesartan medoxomil and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYVINYL ALCOHOL
olmesartan medoxomil and hydrochlorothiazide drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | olmesartan medoxomil and hydrochlorothiazide | 63629-7278 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil and hydrochlorothiazide drug variants not containing POLYVINYL ALCOHOL
Excipient focus: SILICON DIOXIDE
olmesartan medoxomil and hydrochlorothiazide drug variants containing SILICON DIOXIDE
olmesartan medoxomil and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
olmesartan medoxomil and hydrochlorothiazide drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | olmesartan medoxomil and hydrochlorothiazide | 63629-7278 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil and hydrochlorothiazide drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
olmesartan medoxomil and hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | olmesartan medoxomil and hydrochlorothiazide | 33342-173 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil and hydrochlorothiazide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: TALC
olmesartan medoxomil and hydrochlorothiazide drug variants containing TALC
olmesartan medoxomil and hydrochlorothiazide drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
olmesartan medoxomil and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
olmesartan medoxomil and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
